Norio Okamoto - Search Results

Year	Number of Results
2005	1
2006	2
2007	1
2008	4
2009	8
2010	9
2011	12
2012	12
2013	12
2014	9
2015	16
2016	13
2017	12
2018	14
2019	6
2020	10
2021	8
2022	2
2023	1
2024	1

1

Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis Associated With Multiple Heterologous Carcinomas: A Case Report.

Nakano Y, Nishida K, Okamoto N, Gohma I, Yasuhara Y. Nakano Y, et al. Among authors: okamoto n. Cureus. 2024 Feb 21;16(2):e54660. doi: 10.7759/cureus.54660. eCollection 2024 Feb. Cureus. 2024. PMID: 38523968 Free PMC article.

2

Clarithromycin-induced eosinophilic granulomatosis with polyangiitis: A case report.

Nakano Y, Sekinada D, Masuda G, Nishio C, Nishida K, Okamoto N, Gohma I, Esa Y. Nakano Y, et al. Among authors: okamoto n. Respir Med Case Rep. 2023 May 31;44:101878. doi: 10.1016/j.rmcr.2023.101878. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37305218 Free PMC article.

3

A case of thoracic SMARCA4-Deficient undifferentiated tumor successfully treated with combination Ipilimumab-Nivolumab.

Nakano Y, Sekinada D, Kuze Y, Okamoto N, Gohma I, Yasuhara Y. Nakano Y, et al. Among authors: okamoto n. Clin Case Rep. 2022 Dec 13;10(12):e6745. doi: 10.1002/ccr3.6745. eCollection 2022 Dec. Clin Case Rep. 2022. PMID: 36523385 Free PMC article.

4

Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer.

Masuhiro K, Tamiya M, Fujimoto K, Koyama S, Naito Y, Osa A, Hirai T, Suzuki H, Okamoto N, Shiroyama T, Nishino K, Adachi Y, Nii T, Kinugasa-Katayama Y, Kajihara A, Morita T, Imoto S, Uematsu S, Irie T, Okuzaki D, Aoshi T, Takeda Y, Kumagai T, Hirashima T, Kumanogoh A. Masuhiro K, et al. Among authors: okamoto n. JCI Insight. 2022 May 9;7(9):e157915. doi: 10.1172/jci.insight.157915. JCI Insight. 2022. PMID: 35389889 Free PMC article.

5

Balance of Drug Residence and Diffusion in Lacrimal Fluid Determine Ocular Bioavailability in In Situ Gels Incorporating Tranilast Nanoparticles.

Minami M, Otake H, Nakazawa Y, Okamoto N, Yamamoto N, Sasaki H, Nagai N. Minami M, et al. Among authors: okamoto n. Pharmaceutics. 2021 Sep 8;13(9):1425. doi: 10.3390/pharmaceutics13091425. Pharmaceutics. 2021. PMID: 34575501 Free PMC article.

6

Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Yoh K, Matsumoto S, Furuya N, Nishino K, Miyamoto S, Oizumi S, Okamoto N, Itani H, Kuyama S, Nakamura A, Nishi K, Fukuda I, Tsuta K, Hayashi Y, Motoi N, Ishii G, Goto K. Yoh K, et al. Among authors: okamoto n. Lung Cancer. 2021 Sep;159:128-134. doi: 10.1016/j.lungcan.2021.07.015. Epub 2021 Jul 26. Lung Cancer. 2021. PMID: 34333203

7

Exacerbation of liver dysfunction in non-alcoholic steatohepatitis patients during the coronavirus disease 2019 (COVID-19) pandemic.

Asai A, Yasuoka H, Matsui M, Okamoto N, Fukunishi S, Higuchi K. Asai A, et al. Among authors: okamoto n. J Clin Biochem Nutr. 2021 May;68(3):243-245. doi: 10.3164/jcbn.20-136. Epub 2020 Dec 3. J Clin Biochem Nutr. 2021. PMID: 34025027 Free PMC article.

8

The ratio of T790M to EGFR-activating mutation predicts response of osimertinib in 1st or 2nd generation EGFR-TKI-refractory NSCLC.

Tamiya M, Tamiya A, Okamoto N, Taniguchi Y, Nishino K, Atagi S, Hirashima T, Imamura F, Kumagai T, Suzuki H. Tamiya M, et al. Among authors: okamoto n. Sci Rep. 2021 May 5;11(1):9629. doi: 10.1038/s41598-021-89006-9. Sci Rep. 2021. PMID: 33953280 Free PMC article.

9

Hepatic F4/80⁺ CD11b⁺ CD68^- cells influence the antibacterial response in irradiated mice with sepsis by Enterococcus faecalis.

Okamoto N, Ohama H, Matsui M, Fukunishi S, Higuchi K, Asai A. Okamoto N, et al. J Leukoc Biol. 2021 May;109(5):943-952. doi: 10.1002/JLB.4A0820-550RR. J Leukoc Biol. 2021. PMID: 33899953

10

Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients.

Hirashima T, Noda Y, Suzuki H, Nasu S, Tanaka A, Morishita N, Ryota N, Iwata K, Okada Y, Okamoto N. Hirashima T, et al. Among authors: okamoto n. Anticancer Res. 2021 Mar;41(3):1655-1662. doi: 10.21873/anticanres.14928. Anticancer Res. 2021. PMID: 33788762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year